3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
3
Recruiting
3
Terminated
2
Active not recruiting
2
Completed
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Thoracic
3
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Neoplasms
6
Lung Neoplasms
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uveal Melanoma
1
Solitary Pulmonary Nodule
1
Skin Neoplasms
1
Sezary Syndrome
1
Retroviridae Infections
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic cancer, adult
1
Ovarian Neoplasms
1
Mycosis Fungoides
1
Malnutrition
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma
1
Glioblastoma
1
Esophageal Neoplasms
1
Disease
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Barrett Esophagus
1
Interventions
pembrolizumab
49
Carboplatin
44
Magnetic Resonance Spectroscopy
40
Specimen Handling
39
Pemetrexed
34
Cisplatin
25
Blood Specimen Collection
25
durvalumab
17
Paclitaxel
16
osimertinib
15
Radiotherapy
15
Radiosurgery
15
Bevacizumab
15
Gemcitabine
14
atezolizumab
13
Nivolumab
13
Biopsy
13
Drug Therapy
12
Standard of Care
10
Practice Guidelines as Topic
10
Immunoglobulin G
10
Docetaxel
10
130-nm albumin-bound paclitaxel
10
X-Rays
9
Taxes
9
Educational Status
9
Disulfides
9
tislelizumab
8
Etoposide
8
Cetuximab
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Recruiting
×
Lung Neoplasms
×
Hematologic Tests
×
Clear all
NCT07623473
2026-06-03
NIMBLE
Herlev and Gentofte Hospital
Recruiting
1,800 enrolled
NCT06620835
2026-04-29
OPTALK
Groupe Francais De Pneumo-Cancerologie
Phase 2
Recruiting
45 enrolled
NCT06717295
2026-01-02
CCANED-CIPHER
Dysplasia Diagnostics Limited
Recruiting
6,000 enrolled